Skip to content
Search

Latest Stories

NHS prostate enlargement page receives over 16,000 visits following King’s diagnosis

NHS prostate enlargement page receives over 16,000 visits following King’s diagnosis

Buckingham Palace released a statement on Wednesday to inform the public that King Charles III will undergo a "corrective procedure" next week for an enlarged prostate

Following the announcement of the King’s health condition, there has been a dramatic increase in the number of people visiting the NHS webpage for information on prostate enlargement.


According to NHS England, visits to the page offering advice on Benign prostate enlargement (BPE) jumped to one visit every five seconds as news of the King’s diagnosis emerged this week.

The page received 16,410 visits on Wednesday, the day of the Palace announcement, as against 1,414 visits received on Tuesday – a 1061 per cent increase in just a day.

The Palace said that Charles wanted to share his diagnosis so as to encourage more men who may be experiencing symptoms to get their conditions checked.

BPE is common in men over the age of 50, and around 70-80 per cent over the age of 75 are likely to have an enlarged prostate, said Ian Eardley, National Clinical Director for NHS England and a consultant urological surgeon in Leeds.

“Many men worry that having an enlarged prostate means they have an increased risk of developing prostate cancer but this isn’t the case.

“Help is available and there are a number of tests that can be done to rule out cancer.

“The symptoms of an enlarged prostate can be considerably improved by visiting your GP, taking medication and making lifestyle changes and, for most, there is no need for an operation,” the surgeon added.

prostate enlargement

Prostate enlargement or benign prostatic hyperplasia is believed to be caused by hormonal changes as a man gets older.

An enlarged prostate can affect how you pee (urinate), and may cause difficulty starting to pee, a frequent need to pee and difficulty fully emptying your bladder.

But it's not usually a serious threat to health, the NHS explained in its webpage.

“Surgery is usually only recommended for moderate to severe symptoms that have not responded to medicine,” it said.

Sometimes, BPE can lead to complications, such as a urinary tract infection (UTI), chronic urinary retention and acute urinary retention.

You can visit the NHS prostate enlargement page for more information on the symptoms, diagnosis and treatment of benign prostate enlargement.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less